Baseline and Trend of Lymphocyte-to-Monocyte Ratio as Prognostic Factors in Epidermal Growth Factor Receptor Mutant Non-Small Cell Lung Cancer Patients Treated with First-Line Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors.
about
Antacid Use and De Novo Brain Metastases in Patients with Epidermal Growth Factor Receptor-Mutant Non-Small Cell Lung Cancer Who Were Treated Using First-Line First-Generation Epidermal Growth Factor Receptor Tyrosine Kinase InhibitorsThe impact of de novo liver metastasis on clinical outcome in patients with advanced non-small-cell lung cancer.Impact of clinical parameters and systemic inflammatory status on epidermal growth factor receptor-mutant non-small cell lung cancer patients readministration with epidermal growth factor receptor tyrosine kinase inhibitorsA Survival Scoring System for Non-Small Cell Lung Cancer Patients with De Novo Bone MetastasesPrognostic performance of lymphocyte-to-monocyte ratio in diffuse large B-cell lymphoma: an updated meta-analysis of eleven reports.Baseline, Trend, and Normalization of Carcinoembryonic Antigen as Prognostic Factors in Epidermal Growth Factor Receptor-Mutant Nonsmall Cell Lung Cancer Patients Treated With First-Line Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors.Prognostic significance of lymphocyte-to-monocyte ratio in diffuse large B-cell lymphoma: a systematic review and meta-analysis.Identification of the prognostic value of lymphocyte-to-monocyte ratio in patients with HBV-associated advanced hepatocellular carcinoma.Prognostic Significance of the Preoperative Lymphocyte to Monocyte Ratio in Patients With Stage I Non-Small Cell Lung Cancer Undergoing Complete Resection.Combination of platelet count and lymphocyte to monocyte ratio is a prognostic factor in patients undergoing surgery for non-small cell lung cancer.Prognostic value of lymphocyte-to-monocyte ratio among Asian lung cancer patients: a systematic review and meta-analysis.Neutrophil-to-Lymphocyte Ratio Predicts Overall Survival of Advanced Non-Small Cell Lung Cancer Harboring Mutant Epidermal Growth Factor Receptor.Association of the Lung Immune Prognostic Index With Immune Checkpoint Inhibitor Outcomes in Patients With Advanced Non-Small Cell Lung Cancer.Lymphocyte to Monocyte Ratio and Modified Glasgow Prognostic Score Predict Prognosis of Lung Adenocarcinoma Without Driver Mutation.Pretreatment Lymphocyte to Monocyte Ratio as a Prognostic Marker for Advanced Pulmonary Squamous Cell Carcinoma Treated With Chemotherapy.Mean platelet volume and lymphocyte-to-monocyte ratio are associated with shorter progression-free survival in EGFR-mutant lung adenocarcinoma treated by EGFR tyrosine kinase inhibitor
P2860
Q28550276-27D956AB-4971-46B5-B6B9-75008F065B2EQ33773098-5B23A6C1-9E0D-4216-9D05-B7974D2279F9Q36184759-D943D4E1-612F-4ADD-9EDE-B1BFE0832762Q36216134-ED7AF66D-AAE0-4CD9-8C2F-9374389EDDE4Q36940100-0CA74426-2657-4C31-A182-926B3FFE3D3AQ37328319-71E702CE-24CC-44BE-A22B-E898B99CFA46Q38897604-400608F1-38E0-4C36-B747-C66B61757420Q40044138-41F037A3-B7F2-4CC5-9AD7-E452B7E01D35Q40608467-9B1882EC-78D3-4177-97BF-E15D0C6B0361Q42700678-EEAFC15A-DB75-4A5F-86C2-BB96DC8EF1E1Q47125463-9CF3D261-D278-4DC9-ADAD-2BE97499A55DQ47661608-0B7C7F5D-B4FB-4AC0-9E5C-F6FBF79007D5Q50074196-2BFA17E9-6D13-44DF-9AFD-EA77D6394290Q52629205-4FC53BBC-E1E2-4C0A-9FB5-2ABD342D02C3Q55518947-8DCE20E4-3250-4B2C-9C9C-0DB3264B60E8Q58760024-E42991E2-C186-4F2C-8846-4EE293989ED2
P2860
Baseline and Trend of Lymphocyte-to-Monocyte Ratio as Prognostic Factors in Epidermal Growth Factor Receptor Mutant Non-Small Cell Lung Cancer Patients Treated with First-Line Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Baseline and Trend of Lymphocy ...... or Tyrosine Kinase Inhibitors.
@ast
Baseline and Trend of Lymphocy ...... or Tyrosine Kinase Inhibitors.
@en
type
label
Baseline and Trend of Lymphocy ...... or Tyrosine Kinase Inhibitors.
@ast
Baseline and Trend of Lymphocy ...... or Tyrosine Kinase Inhibitors.
@en
prefLabel
Baseline and Trend of Lymphocy ...... or Tyrosine Kinase Inhibitors.
@ast
Baseline and Trend of Lymphocy ...... or Tyrosine Kinase Inhibitors.
@en
P2093
P2860
P1433
P1476
Baseline and Trend of Lymphocy ...... tor Tyrosine Kinase Inhibitors
@en
P2093
Chia-Cheng Tseng
Chien-Hao Lai
Chin-Chou Wang
Huang-Chih Chang
Hung-Chen Chen
Kuo-Tung Huang
Mao-Chang Su
Meng-Chih Lin
Tung-Ying Chao
Ya-Chun Chang
P2860
P304
P356
10.1371/JOURNAL.PONE.0136252
P407
P577
2015-08-27T00:00:00Z